VTVT logo

vTv Therapeutics (VTVT) Company Overview

Profile

Full Name:

vTv Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 30, 2015

Indexes:

Not included

Description:

vTv Therapeutics is a biopharmaceutical company focused on developing innovative therapies for chronic diseases. They aim to improve patient outcomes through their research on drug candidates targeting conditions like diabetes and Alzheimer's. Their work combines science and technology to create effective treatments for unmet medical needs.

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 21, 2023

Analyst ratings

Recent major analysts updates

Dec 9, 24 Alliance Global Partners
Buy
Mar 7, 23 HC Wainwright & Co.
Buy
Aug 17, 22 Northland Capital Markets
Outperform
Feb 18, 22 Cantor Fitzgerald
Overweight
Feb 10, 20 HC Wainwright & Co.
Buy
Feb 10, 20 H.C. Wainwright
Buy
May 30, 19 HC Wainwright & Co.
Buy
May 30, 19 H.C. Wainwright
Buy
May 6, 19 Northland Capital Markets
Outperform
Apr 10, 18 Stifel Nicolaus
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for vTv Therapeutics?
  • Does vTv Therapeutics pay dividends?
  • What sector is vTv Therapeutics in?
  • What industry is vTv Therapeutics in?
  • What country is vTv Therapeutics based in?
  • When did vTv Therapeutics go public?
  • Is vTv Therapeutics in the S&P 500?
  • Is vTv Therapeutics in the NASDAQ 100?
  • Is vTv Therapeutics in the Dow Jones?
  • When was vTv Therapeutics's last earnings report?
  • When does vTv Therapeutics report earnings?
  • Should I buy vTv Therapeutics stock now?

What is the ticker symbol for vTv Therapeutics?

The ticker symbol for vTv Therapeutics is NASDAQ:VTVT

Does vTv Therapeutics pay dividends?

No, vTv Therapeutics does not pay dividends

What sector is vTv Therapeutics in?

vTv Therapeutics is in the Healthcare sector

What industry is vTv Therapeutics in?

vTv Therapeutics is in the Biotechnology industry

What country is vTv Therapeutics based in?

vTv Therapeutics is headquartered in United States

When did vTv Therapeutics go public?

vTv Therapeutics's initial public offering (IPO) was on July 30, 2015

Is vTv Therapeutics in the S&P 500?

No, vTv Therapeutics is not included in the S&P 500 index

Is vTv Therapeutics in the NASDAQ 100?

No, vTv Therapeutics is not included in the NASDAQ 100 index

Is vTv Therapeutics in the Dow Jones?

No, vTv Therapeutics is not included in the Dow Jones index

When was vTv Therapeutics's last earnings report?

vTv Therapeutics's most recent earnings report was on Nov 12, 2024

When does vTv Therapeutics report earnings?

The next expected earnings date for vTv Therapeutics is Mar 13, 2025

Should I buy vTv Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions